Morphine and morphine-6-glucuronide plasma concentrations and effect in cancer pain
- 29 February 1996
- journal article
- clinical trial
- Published by Elsevier BV in Journal of Pain and Symptom Management
- Vol. 11 (2), 95-102
- https://doi.org/10.1016/0885-3924(95)00148-4
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Morphine-6-glucuronide concentrations and opioid-related side effects: a survey in cancer patientsPain, 1995
- Intrathecal morphine-3-glucuronide does not antagonize spinal antinociception by morphine or morphine-6-glucuronide in ratsEuropean Journal of Pharmacology, 1993
- Lack of effect of morphine-3-glucuronide on the spinal antinociceptive actions of morphine in the rat: an electrophysiological studyPain, 1993
- Morphine Pharmacokinetics and Metabolism in HumansClinical Pharmacokinetics, 1993
- ANALGESIC EFFICACY AND CSF PHARMACOKINETICS OF INTRATHECAL MORPHINE-6-GLUCURONIDE: COMPARISON WITH MORPHINEBritish Journal of Anaesthesia, 1990
- ANALGESIC ACTIVITY OF MORPHINE-6-GLUCURONIDEThe Lancet, 1988
- New Drugs: Controlling symptoms in advanced cancerBMJ, 1988
- Morphine-6-glucuronide, a potent mu agonistLife Sciences, 1987
- POTENTIAL ANALGESIC CONTRIBUTION FROM MORPHINE-6-GLUCURONIDE IN CSFThe Lancet, 1987
- Analgesic Effect of Morphine GlucuronidesThe Tohoku Journal of Experimental Medicine, 1971